financetom
Business
financetom
/
Business
/
UTI AMC's profit declines 8% to ₹183 crore in September quarter
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
UTI AMC's profit declines 8% to ₹183 crore in September quarter
Oct 18, 2023 2:42 PM

UTI Asset Management Company on Wednesday reported an 8 percent decline in profit after tax to ₹183 crore in the September quarter.

It had posted a profit after tax of ₹200 crore in the same quarter of the preceding fiscal, according to a regulatory filing.

The company's total revenue from operations dropped 7 percent to ₹404 crore during the quarter under review. In the year-ago period, the same was at ₹435 crore.

For the quarter ended September 30, 2023, UTI Mutual Fund's average assets under management stood at ₹2.67 lakh crore and it had a market share of 5.68 percent.

Also Read: Titagarh Rail Systems Q2 Results | Net profit rises 47% to ₹71 crore, revenue up 54%

Imtaiyazur Rahman, chief executive officer of UTI AMC, said the Indian mutual fund industry has constantly worked towards building financial literacy in the country for creating awareness about various products and in enabling investors to make informed investment decisions.

"With our growing geographical and digital reach in the country and our expertise in investment management combined with a large suite of products, UTI is well placed to capitalise on the opportunities offered by the markets," he added.

UTI AMC is the investment manager of UTI Mutual Fund.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bank of Hawaii Q4 Earnings, Revenue Increase
Bank of Hawaii Q4 Earnings, Revenue Increase
Jan 27, 2025
07:00 AM EST, 01/27/2025 (MT Newswires) -- Bank of Hawaii ( BOH ) reported Q4 earnings Monday of $0.85 per diluted share, up from $0.72 a year earlier. Analysts polled by FactSet expected $0.83. Revenue for the quarter ended Dec. 31, expressed as the sum of net interest income and total non-interest income, was $163.2 million, up from $158.1 million...
Emerson to buy rest of AspenTech for $265 per share
Emerson to buy rest of AspenTech for $265 per share
Jan 27, 2025
Jan 27 (Reuters) - Emerson Electric ( EMR ) will acquire all outstanding shares of AspenTech it does not already own for $265 per share, the companies said on Monday. ...
Before Trump's return, some top U.S. firms had already gone cold on diversity pledges
Before Trump's return, some top U.S. firms had already gone cold on diversity pledges
Jan 27, 2025
LONDON (Reuters) - Some large U.S. companies had made limited progress in promoting women and were diluting or abandoning equal opportunity initiatives even before President Donald Trump launched last week a nationwide campaign to scrap them, underscoring a shift in corporate priorities. Shortly after taking office on Jan. 20, Trump issued sweeping executive orders to dismantle diversity, equity and inclusion...
Veru's experimental drug helps Wegovy patients preserve muscle in study
Veru's experimental drug helps Wegovy patients preserve muscle in study
Jan 27, 2025
Jan 27 (Reuters) - Veru ( VERU ) said on Monday its experimental drug, in combination with Novo Nordisk's weight-loss treatment Wegovy, helped preserve muscle in older patients with obesity, meeting the main goal of a mid-stage study. The study was testing Veru's ( VERU ) oral drug, enobosarm, in patients aged 60 and above. The drug targets androgen hormones,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved